RICARDO RUIZ: Open Payments
NPI 1477110336 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,004 in 24 payments from 8 companies in 2025. Trend: 2023 $666 · 2024 $788 · 2025 $4,004
Consulting: $2,616Food & beverage: $816Travel & lodging: $390Education: $182
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $3,199 |
| Janssen Biotech, Inc. | 5 | $271 |
| Gilead Sciences, Inc. | 7 | $233 |
| Ardelyx, Inc. | 1 | $161 |
| Aimmune Therapeutics, Inc. | 2 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $38 |
| Madrigal Pharmaceuticals | 1 | $28 |
| QOL Medical, LLC | 1 | $15 |
Products named: TREMFYA, IBSRELA, ZENPEP, DUPIXENT, XIFAXAN, REZDIFFRA, Sucraid.
Industry payments across FL — which companies pay providers there.
